SCHEMBL6469818

SCHEMBL6469818

COC(=O)c1c(C)[nH]c(C)c1-c1ccc(Cl)c(Cl)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.67
ALDH1A1 P00352 4/20 0.67
POLB P06746 1/20 0.67
LMNA P02545 3/20 0.62
HTT P42858 3/20 0.60
GAA P10253 2/20 0.60
TSHR P16473 1/20 0.60
MEN1 O00255 3/20 0.58
MAPT P10636 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
SLC6A3 Q01959 6/20 0.50
SLC6A2 P23975 3/20 0.47
RAB9A P51151 1/20 0.47
NOTUM Q6P988 1/20 0.47
HPGD P15428 1/20 0.46
CHUK O15111 1/20 0.43
AR P10275 1/20 0.43
KDM4E B2RXH2 1/20 0.43
PKM P14618 1/20 0.43
RCE1 Q9Y256 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6469795 0.82 ALDH1A1 (0.69) KMT2AALDH1A1POLBLMNAHTT
SCHEMBL6469579 0.79 ALDH1A1 (0.79) KMT2AALDH1A1POLBLMNAHTT
SCHEMBL6464519 0.79 ALDH1A1 (0.79) KMT2AALDH1A1POLBLMNAHTT
SCHEMBL6469625 0.79 LMNA (0.69) KMT2AALDH1A1POLBLMNAHTT
SCHEMBL6469553 0.78 KMT2A (0.77) KMT2AALDH1A1POLBLMNAHTT
SCHEMBL6468908 0.78 LMNA (0.94) KMT2AALDH1A1POLBLMNAHTT
SCHEMBL6466951 0.77 ALDH1A1 (0.75) KMT2AALDH1A1POLBLMNAHTT
SCHEMBL6465905 0.77 ALDH1A1 (0.75) KMT2AALDH1A1POLBLMNAHTT
SCHEMBL6468403 0.76 LMNA (0.69) KMT2AALDH1A1POLBLMNAHTT
SCHEMBL6465316 0.75 ALDH1A1 (0.73) KMT2AALDH1A1POLBLMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050101657-A1 Pyrrole derivatives for preventing or treating cancer sensitive to hormones; administered with luteininzing hormone releasing hormone derivative TAKEDA CHEMICAL INDUSTRIES LTD. (JP) 2005-05-12 US disclosed
EP-1466902-A1 ANDROGEN RECEPTOR ANTAGONISTS Takeda Chemical Industries, Ltd. (JP) 2004-10-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050101657-A1 Pyrrole derivatives for preventing or treating cancer sensitive to hormones; administered with luteininzing hormone releasing hormone derivative SHBG, PRLHR, FSHR KMT2A 2015/4885ALDH1A1 2144/4885POLB 3507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.